AFT Pharmaceuticals logo

AFT - AFT Pharmaceuticals News Story

NZD4.68 0.1  2.0%

Last Trade - 18/06/21

Sector
Healthcare
Size
Small Cap
Market Cap £246.1m
Enterprise Value £265.7m
Revenue £56.9m
Position in Universe 444th / 1914

BUZZ-NZ's AFT Pharma hits 5-week high as co licenses Maxigesic IV to 6 countries

Wed 5th May, 2021 1:49am
** Shares of AFT Pharmaceuticals  AFT.NZ  rise as much as
3.2% to NZ$4.85, their highest since March 31 
    ** The drugmaker to license Maxigesic IV into Colombia,
Peru, Chile, Ecuador, Bolivia, and Uruguay  urn:newsml:reuters.com:*:nASXwvKVy
    ** Co says the medicine is now available in 17 Latin
American and Caribbean countries
    ** Maxigesic IV is an intravenous pain-relief formulation to
be used post-operatively in hospitals where patients cannot take
an oral medicine
    ** Stock down 14.7% this year, as of last close
    
  

 (Reporting by Harish Sridharan in Bengaluru)
 ((harish.sridharan@thomsonreuters.com))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.